ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Reduced-Graphene Oxide Nanofiltration Membranes Intercalated by Conjugated Polyaromatics: Towards High Monovalent Salt Rejections.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Graphene oxide (GO) nanofiltration (NF) membranes have emerged as promising candidates for processing of aqueous streams, due to fast water transport characteristics and excellent chemical stability in harsh operating environments. Their practical applications under realistic high salt/solute concentration conditions are challenged by a lack of systematic approaches to control selectivity, as well as membrane swelling and mechanical stability. Here, we show that intercalation of rGO (reduced GO) membranes with polyaromatic conjugated molecules of different structural classes is an effective strategy to enhance and tune their performance. Specifically, these membranes allow entry into a "deep NF" regime with remarkably high inorganic monovalent salt rejections (NaCl, 75-85%) and near-total divalent salt rejections (Na
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.